NNE provided a pre-study to support management decision on feasibility for establishing in-house API development and production facility, including an initial master plan.
The customer's key drivers were:
1. CAPEX/OPEX
2. Attracting investors for funding of the project.
NNE's pre-study aimed to support the customer's internal management decision on in-house development and manufacturing feasibility, as well as help the customer attract investors for funding by showcasing the assets of the project. We thus developed a prospect to apply for funding, visuals to support key points and an initial cost estimate and schedule.
Fact box
Customer
Confidential
Country
Denmark
Technology
Active pharmaceuticals ingredients and monoclonal antibodies
Format
Workshop with customer
Duration
2 workshops
Total of 4 weeks
Project completion
2019
Size
48,000 m2
Services provided
Feasibility study
